(Q48864069)

16 February 2018

title

Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. (English)

1 reference

16 February 2018

author name string

Adam J Schwarz

1

1 reference

16 February 2018

Peng Yu

2

1 reference

16 February 2018

Bradley B Miller

3

1 reference

16 February 2018

Sergey Shcherbinin

4

1 reference

16 February 2018

James Dickson

5

1 reference

16 February 2018

Michael Navitsky

6

1 reference

16 February 2018

Abhinay D Joshi

7

1 reference

16 February 2018

Michael D Devous

8

1 reference

16 February 2018

Mark S Mintun

9

1 reference

16 February 2018

language of work or name

English

0 references

publication date

2 March 2016

1 reference

16 February 2018

published in

Brain

1 reference

16 February 2018

volume

139

1 reference

16 February 2018

issue

Pt 5

1 reference

16 February 2018

page(s)

1539-1550

1 reference

16 February 2018

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

A Semiautomated Method for Quantification of F 18 Florbetapir PET Images

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Tau PET imaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Clinical and multimodal biomarker correlates of ADNI neuropathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

In vivo tau imaging: obstacles and progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW023

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWW023

1 reference

16 February 2018

1 reference

16 February 2018